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Abstract
Background: Aberrant dark adaptation is common to many ocular diseases and pathophysiological conditions,
including vitamin A deficiency, cardiopulmonary diseases, and hypoxia. Scotopic vision and pupillary responsiveness
have typically been measured using subjective, time-consuming methods. Existing techniques are particularly
challenging for use in developing country settings, where vitamin A deficiency remains a major public health problem.
Our aim was design a compact, low cost, and easily operated device to assess dark adaptation in the field.
Methods: The Portable Field Dark Adaptometer (PFDA) incorporates a digital camera, a retinal bleaching flash, and a
Ganzfeld light source inside a pair of light-obscuring goggles. After a ~10 min period of dark adaption, the infrared
camera digitally records afferent pupillary responses to graded light stimuli (−2.9 to 0.1 log cd/m2). We tested this
device in a variety of field settings to assess: a) ease of use and b) whether test data could clearly and accurately depict
the well-known dose-response relationship between light intensity and pupil contraction. A total of 822 videos were
collected. We used an open source video analysis software to measure pupil size in pixel units. Pupillary responsiveness
was expressed as the percent change in pupil size from pre- to post-light exposure. Box plots, t test, and multi-level
mixed effects linear regression modeling were used to characterize the relationship between light intensity and
pupillary response.
Results: The PFDA was employed with only minor technical challenges in Bangladesh, Kenya, Zambia, and Peru. Our
data show a clear linear increase in pupillary constriction with increasing log light intensity. Light intensity was a strong
predictor of pupillary response, regardless of baseline pupil size.
Conclusions: The consistent physiological response demonstrated here supports the use of the PFDA as a reliable tool
to measure dark adaptation. As a next step, PFDA measurements will be validated against biochemical indicators of
vitamin A status and hypoxemia. Ultimately, this new technology may provide a novel approach for nutritional
assessment, with potential clinical applications.
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Background
Dark adaptation is the visual adjustment that occurs
when transitioning from a high- to low-light settings. It
is characterized by pupil dilation and increased activity
of the rod photoreceptors that line the retina. A wide
variety of pathophysiological conditions can impair dark
adaptation. The biochemical relationship between vita-
min A and scotopic vision was first described in 1925
when Holm observed that regeneration of visual purple
(rhodopsin) was slowed in vitamin A deficient rats [1].
The eye’s adaptability in dim light is also compromised
in hypoxic individuals. This was first noted in fighter pi-
lots during World War II, who described difficulties with
their vision when flying at high altitudes; mountain
climbers are similarly affected [2]. There is now a well-
documented association between oxygen deficiency and
impaired dark adaptation [3]. Night vision is extremely
sensitive to even mild hypoxia, regardless of the under-
lying cause. For example, dark adaptation is impaired in
patients with carotid artery disease due to their de-
creased arterial oxygen saturation [4].
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Given the functional consequences of impaired dark
adaptation, it has been extensively studied in both aca-
demic and military research as a sequelae of disease and
marker of individual capacity [5, 6]. Tests for dark adap-
tation have typically focused on identification of a pa-
tient’s pupillary threshold using a stepwise series of light
intensities [7]. The pupillary threshold is the lowest light
intensity to cause a significant pupillary contraction in a
dark-adapted eye [8]. Over a dozen dark adaptometers
were produced during the 1940s, ranging from Wald’s
“portable dark adaptometer” for vitamin A research to the
British Army Medical Service’s “Middle East adaptometer”
designed to test night vision in soldiers [1, 9–11]. These
devices relied on subjective responses by an examiner and,
in the end, did not correlate with biochemical measures of
vitamin A status [12]. Until recently, the Goldmann-
Weekers dark adaptometer (Haag-Streit) served as the
gold-standard for to assess dark adaption; however, its size
and complexity rendered this device unsuitable for field
use.
To address the need for a portable and relatively inex-
pensive calibrated light source, Congdon et al developed
and tested the Scotopic Sensitivity Tester-1 (SST-1; LKC
Technologies, Maryland, USA). They found that SST-1
measures were significantly correlated with serum ret-
inol concentration [8, 13]. In the hands of trained
personnel, the SST-1 showed potential as a non-invasive
measure of population vitamin A status [14, 15]; how-
ever, it still relied on subjective measurements, as an
examiner had to observe “major” pupillary changes, and
required a dark room. Nearly a century after the first
proposal that dark adaptation could serve as an indirect
measure of vitamin A status, we remain without a reli-
able, field-friendly dark adaptometer.
We tested the ease of use and performance of a novel
Portable Field Dark Adaptometer (PFDA) under field
conditions. Performance was graded on the device’s abil-
ity to accurately and clearly depict the well-known dose-
response relationship between pupil contraction and
light intensity.
Methods
Device design and testing
The PFDA is comprised of a rubber shell housing, de-
signed to fit snugly to the contours of the face, with soft
foam padding around the eyes to ensure that no light
enters once the goggles are in place. It is secured with a
wide head strap (Fig. 1). This design creates a mobile
dark room such that assessments can be done outdoors
or in ambient light settings. An infrared mini-camera is
mounted inside the right eyepiece to record pupillary re-
sponse and aberrant activities (e.g., blinking, looking
away) that may impact data quality. The infrared tech-
nology enables examiners and readers to easily
Fig. 1 Schematic diagram of the Portable Field Dark Adaptometer (PFDA) developed to assess impaired pupillary responses to a graded series of
Ganzfeld light stimuli applied within a pair of “dark-room” goggles (a,b) with an embedded microcircuit design (c) and regulated by a laptop-powered
controller box (d)
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distinguish between the pupil and iris, regardless of the
color of the iris (Fig. 2). Testing stimuli are generated
from a Ganzfeld (whole retina) 526 nm wavelength
(green) light emitting diode (LED). Both eyepieces con-
tain discrete LED flash units for baseline retinal bleach-
ing. For test stimuli in the left eye, the pattern can be
customized from a continuous linear trajectory to a
stepwise series of 0.4 log increments over 12 steps, span-
ning −3.57 to 0.348 log cd/m2. Retinal bleaching and
light intensity, sequence, and stimulus timing are all
controlled by custom software on a laptop or netbook.
The software interface records and links patient infor-
mation to the PFDA test, prompts and guides examiners
through the evaluation procedures, and stores and saves
the video files for later quality control and analysis.
Other components used in the assembly of the PFDA
were modular and off-the-shelf to permit inexpensive
manufacturing as well as replacement or service when
needed.
To test the quality of the Ganzfeld illumination, a
comparison of the angular profile (dropoff ) in light in-
tensity was performed on both the SST-1 device and a
mock-up of the dual diffuser stack as constructed in the
PFDA. The measurement was made by placing a silicon
photodiode 2.75" in front of the dual diffuser stack (or
the SST-1/VA-20 housing) while rotating the device
through a range of −70 to +70°.
Field testing
We developed our first iteration of the PFDA in 2003
during the initial phases of the JiVitA-1 vitamin A sup-
plementation trial in Bangladesh [16]. Our aim in testing
the first prototype was to determine the minimum time
necessary for the dark adaptation process to be fully
completed after retinal bleaching (data unpublished).
With the development of new prototypes came field ac-
ceptability studies in Kenya and Bangladesh among
married women of reproductive age and school-aged
children, respectively (Table 1). Technical specifications
in this manuscript refer to the currently available PFDA
model. This standardized, field-ready, and precisely cali-
brated prototype was tested in a sample of preschool-
aged children in Zambia and in Peruvian adults.
Bangladesh, Kenya, and Zambia were targeted due to
their classification as countries with a severe vitamin A
deficiency public health problem, i.e., where ≥20 % of
preschool-aged children or pregnant women [17]. PFDA
assessments were added to ongoing research in all three
countries to test the impact of vitamin A deficiency con-
trol interventions. The research site in Peru was estab-
lished to study geographic variation in chronic disease
risk [18]. PFDA measurements were added based on the
hypothesis that, in individuals with low arterial oxygen
saturation, there would be inadequate provision of oxy-
gen to the retina, negatively impacting dark adaptation.
Details of these study populations and PFDA summary
measurements are presented in Table 1. Study protocols
were approved by Institutional Review Boards at the
Johns Hopkins Bloomberg School of Public Health
(Bangladesh, Zambia, and Peru) and Wageningen Uni-
versity (Kenya), as well as by local ethics review commit-
tees (the Bangladesh Medical Research Council; the
Ethical Review Board of the Tropical Diseases Research
Centre in Zambia; the Institutional Review Board at
Universidad Peruana Cayetano Heredia in Peru, and the
Ethics and Research Committee of Kenyatta National
Hospital in Kenya). Written (Peru and Kenya) or oral
consent (Bangladesh and Zambia) were obtained from
either study subjects (Bangladesh and Peru) or their
parents (Kenya and Zambia).
Training requirements for operation of the PFDA are
minimal. In each of the sites, examiners were trained in a
half-day session by one of the device’s developers (ABL).
Training included an overview of dark adaptation,
Fig. 2 Infrared imaging allows the visualization of an eye in complete “dark-room” conditions while also enhancing pre (a) and post-stimulus
(b) pupillary measurement due to the clear differentiation of the pupil-iris boundary, irrespective of iris color
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introduction to the device, use of the custom software,
interactions with study subjects, testing procedures
(described below), and trouble-shooting in the field. All
trainees tested the PFDA procedures on volunteers. The
strongest candidates were selected based on the devel-
oper’s assessment of aptitude, with emphasis on the
trainee’s ability to interact and guide subjects through the
testing phase. Selected examiners continued with practice-
testing on a daily basis for approximately one week, with
oversight and regular feedback provided by a supervisor.
Assessment procedure
Examiners first attach the PFDA googles and adjust them
until the subject is comfortable. He or she checks the per-
imeter of the goggles using a bright flashlight to identify
and correct errant light penetration through gaps. After
instructing the subject to open his or her eyes and look
forward, the examiner initiates the test using the custom
software. This begins with the bleaching of both retinas
with a bright flash of light, exceeding 3400 cd-s/m2. A 10-
min countdown then ensues, during which time the sub-
ject’s vision is expected to fully dark-adapt. The 10-min
adaptation period is based on previous studies of dark
adaptation, as well as testing results from the first PFDA
prototype [8, 15]. A set of toy plastic animals was used
during the dark adaptation period of younger children, to
keep them from touching their goggles and disturbing
their dark adaptation process. They were asked to feel and
guess the animal as a game. At the end of the adaptation
period, the software issues a warning to the operator that
the test phase is about to begin. He or she then directs the
subject to open their eyes and look forward. The exam
protocol consists of nine light stimuli ranging from −2.9
to 0.1 log cd/m2, comparable to previous studies using the
SST-1 device [8, 15]. Stimuli increase in increments of 0.4
log cd/m2 and last for one second each. There is a 10-s
rest between stimuli to provide the pupil time to re-dilate
to its pre-stimulus size. Prior to each of the nine stimuli,
participants are reminded to open their eyes wide and
look straight forward. They are also asked to blink as little
as possible during the test. Aberrant activities like blinking
and looking away are also recorded and can be actively
monitored and discouraged during the testing window. At
the end of test, the video is automatically saved on the lap-
top or netbook. Overall, the duration of PFDA testing pro-
cedures is approximately 15 min per subject.
Video analysis
PFDA video recordings are assessed by a trained reader
using Tracker 4.85 (Douglas Brown, Davidson, North
Carolina), an open source video analysis and modeling
software. The software’s “Tape Measure” tool enables
Table 1 Pupil response metrics in four study populations using the Portable Field Dark Adaptometer (2010–2013)
Country, Assessment Year Bangladesh, 2010 Kenya, 2010 Zambia, 2012 Peru, 2013
Study Population Pregnant women School-aged children Preschool-aged children Adults
n 242 184 305 91
Male, n (%) 0 (100.0) 79 (43.0) 148 (48.5) 44 (48.4)
Mean age ± SD 23.4 ± 6.1 9.2 ± 1.9 5.7 ± 1.3 55.1 ± 10.9
Mean relative change ± SD in pupil diameter (%)1
All stimuli: -2.9 to 0.1 log cd/m2 −19.8 ± 5.0 −15.5 ± 5.8 −17.0 ± 6.8 −22.7 ± 8.0
Low intensity: −2.9 to −1.3 log cd/m2 −14.5 ± 5.3 −9.4 ± 5.1 −9.2 ± 5.9 −16.3 ± 7.6
High intensity: −0.9 to 0.1 log cd/m2 −26.2 ± 5.4 −23.1 ± 7.5 −26.7 ± 8.3 −30.5 ± 8.8
Mean response time (s) 2
All stimuli: −2.9 to 0.1 log cd/m2 1.27 ± 0.31 1.02 ± 0.16 1.11 ± 0.21 1.13 ± 0.18
Low intensity: −2.9 to −1.3 log cd/m2 1.21 ± 0.29 0.90 ± 0.19 1.00 ± 0.21 1.07 ± 0.22
High intensity: −0.9 to 0.1 log cd/m2 1.35 ± 0.44 1.17 ± 0.17 1.24 ± 0.25 1.20 ± 0.22
Mean +/- SD pupillary threshold (log cd/m2) −1.87 ± 0.75 −1.20 ± 0.83 −1.34 ± 0.70 −1.91 ± 0.81
Distribution of pupillary thresholds (%)3
Good: −2.9 to −2.1 cd/m2 49.2 23.4 20.7 59.3
Adequate: −1.7 to −0.9 cd/m2 42.1 42.9 55.3 29.7
Impaired: −0.5 to 0.1 cd/m2 8.7 33.7 24.0 11.0
1Pre- to post-stimulus change pupil diameter (in pixels), expressed as proportion of pre-stimulus diameter; figures are mean +/- SD; lower values reflect a greater
response/better dark adaptation
2Absolute value of the difference in video frame number from pre- to post-stimulus, divided by 30 frames/s; higher values reflect a faster response/better
dark adaptation
3Pupillary threshold defined as first stimulus at which pupil diameter decreased by 20 % or more; abnormal as defined by Congdon et al. [8], i.e., pupillary
threshold > = −0.5 log cd/m2
Labrique et al. BMC Ophthalmology  (2015) 15:74 Page 4 of 9
readers to measure pupil diameter in pixels for any se-
lected frame. For each subject’s video, data are recorded
on the pupil’s starting diameter. The PFDA software
adds an “LED” caption in the upper left-hand corner of
all video frames recorded during each one-second stimu-
lus. Pre-stimulus diameter is measured one frame prior
to light exposure. The post-stimulus measurement is
taken at the frame showing the smallest pupil diameter
(Fig. 4). In addition to the pupil measurements, the
reader records pre- and post-stimulus frame numbers.
These can be used to calculate pupil dynamics such as
velocity of response and pupil resent time. Additionally,
quality assurance indicators are recorded for each light
stimulus and/or the test as a whole, including: blinking;
pupil not centered in image; presence of fog on the lens;
and light let into the goggle, e.g., if the goggles were ad-
justed. This information can also be used in assessing
data quality, rating testers, and providing feedback to
the field. Video files from children with adequate [see
Additional file 1] and impaired dark adaptation [see
Additional file 2] are available as online supplementary
materials.
Data analysis
Three primary analytic metrics were developed for the
PFDA: pupillary responsiveness (R), dynamics (D), and
threshold (PT). Pupillary responsiveness is calculated as
the percent change in pupil diameter from pre- to post-
stimulus. Subjects with better dark adaptation would
have a stronger, i.e., a more negative, response. Pupil dy-
namics are calculated by taking the absolute value of the
difference in frame numbers from pre- to post-stimulus
and then dividing by 30, i.e., the number of frames per
second. A faster response would be expected of healthy
subjects compared to impaired ones. Each subject’s test
yields nine pupillary response variables and nine vari-
ables related to pupil dynamics. For analysis purposes,
these variables are generally summarized by taking the
mean responsiveness or mean time over all nine stimuli
(−2.9 to 0.1 log cd/m2), low light stimuli (−2.9 to −1.3
log cd/m2), or high light stimuli (−0.9 to 0.1 log cd/m2).
The latter grouping, referred to here as “high light stim-
uli,” is intended to capture the range of stimuli where
even a vitamin A deficient population would be expected
to respond [7]. Pupillary threshold is defined as the low-
est light intensity that stimulated a ≥15 % relative
change in the subject’s pupil diameter. Pupillary thresh-
old, when evaluated by Congdon et al, was originally
coded based on the stimulus number (i.e., stimulus 1
through stimulus 9). These were converted to light
intensity (log cd/m2), based on the device’s initial cali-
bration. Lower pupillary threshold values have historic-
ally been associated with healthy, vitamin A replete
individuals, interpreted as a lower intensity of light
required to trigger a significant, or major, response. Ab-
normal or “impaired” dark adaptation has been defined
by a pupillary threshold ≥ -0.5 log cd/m2. This cut-off
was based on data from 56 healthy American children
with dark irises and has been employed previously in re-
search using the SST-1 device [8, 14]. For analysis, we
used box plots to examine distributions of pupillary re-
sponse to individual light stimuli. A multilevel mixed ef-
fects model with undefined covariance was used to test
the effect of light intensity on pupillary responsiveness,
as characterized by the PFDA, controlling for starting
pupil diameter. All statistical analyses were performed
with Stata 12 statistical software (StataCorp LP, College
Station, Texas).
Results and discussion
As shown in Fig. 3, the dual diffuser stack produced a
distribution that was slightly broader than the ideal
Lambertian distribution (i.e., uniform scatter) and may
represent a minor level of inherent measurement error
or a mild, non-uniform illumination from the LED itself
that was not completely dispersed by the dual diffuser
stack.
Testing confirmed the functionality of the PFDA
under challenging field conditions. Its size and weight
allowed it to be carried long distances to areas unreach-
able by car. Minimally trained field workers collected
readable videos in a variety of settings, often outside in
bright sunlight. Testers encountered some early chal-
lenges in connecting the PFDA convertor box/goggles to
the computer associated with the use of older “Apple
talk” cables, which were replaced by standard USB ca-
bles. There were also issues with computer battery life,
which were resolved in one field setting by switching
from laptop to netbook computers. Examiners carried
out an average of ~10 tests per day. Across all four pop-
ulations, the device was acceptable to a range of subjects
from pregnant women to young, preschool-aged chil-
dren. No tests were terminated due to subject discom-
fort or concerns. In some cases, on exceptionally hot
days, the headset resulted in a lot of perspiration around
the eyes; this did not affect the test integrity. Subjects
appreciated the disinfection of the goggles with dispos-
able alcohol swabs between users.
A total of n = 822 videos were collected across the
four sites, with mean (± SD) pupillary response ranging
from -15.5 ± 5.8 log cd/m2 in Kenyan school children
to −22.7 ± 8.0 log cd/m2 in Peruvian adults. Estimates
of pupil dynamics were slowest in the Kenya dataset,
similar to what was seen with pupillary response. In all
studies, response time was faster to the low intensity
stimuli; we also observed the greatest variance in re-
sponse time between countries across the low intensity
stimuli. Mean pupillary thresholds were within the same
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range as previously reported findings [7] and show a similar
pattern as the other metrics; the highest threshold was in
Kenya, where 33.7 % of children were classified as having
impaired dark adaptation. Results were roughly equivalent
in the data from Bangladesh and Peru, where the preva-
lence of impaired dark adaptation was ~10 %. Although
biochemical data are not yet available to test this hypo-
thesis, the marked variation in pupil response metrics
across sites is likely due to differences in vitamin A status.
Young children, in particular, are at an increased risk of
vitamin A deficiency [19], which we suspect as the
underlying cause of impaired dark adaptation in our
preschool- and school-aged samples. Ethnic differences
could conceivably influence our finding as well. How-
ever, the challenge of measuring pupil response in
darkly pigmented eyes has largely been overcome with
the use of infrared technology.
There was a clear trend of increased pupillary response
with increasing light intensity across all four sites (Fig. 4).
Regression modeling confirmed a highly significant rela-
tionship between pupillary response and light intensity,
irrespective of starting pupil diameter, with values ranging
from −2.6 log cd/m2 (95 % CI: −2.7, −2.5) among
reproductive-aged women in Bangladesh to −3.7 log
cd/m2 (95 % CI: −3.9, −3.6) in Zambian preschool-aged
children. While validation of the PFDA was beyond the
scope of this work, the design of the PFDA was guided by
the SST-1 device, which compares favorably to the
Goldmann-Weekers Dark Adaptometer—previously con-
sidered the gold standard for assessing dark adaptation
[13]. Employment of an infrared camera and objective
video analysis may represent an advance over these
previous psychophysical testing protocols. We expect
that the PFDA’s automated test procedure would also
improve the reliability of dark adaptation assessments
by reducing variability associated with examiner tech-
nique [20]. We did note some instances, particularly in
the Zambia dataset (2 % of measurements; 12 % of
children), of pupil dilation in response to light stimuli
(Fig. 4). While not statistically significant, the mean age
of children with implausible values was lower than that
of their peers (difference = 0.37 ± 0.44 years; p = 0.1).
These implausible values likely reflect the challenge of
working with younger subjects, who may be less able to
keep their eyes fixed straight ahead for the entire testing
period, thus complicating pupil diameter measure-
ments. They also underscore the need for close super-
vision of examiners in the field, who must continuously
monitor eye position on the computer screen and
encourage their subjects, particularly children, to look
straight ahead with their eyes wide open during the
testing phase.
Fig. 3 Comparison of the angular profile in light intensity between the VA-20 Ganzfeld source in the commercial SST-1 device, the mock-up of the
dual diffuser stack in the Portable Field Dark Adaptometer, and the ideal Lambertian reflectance across an angular illumination range of -70 to +70°
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Fig. 4 Trend in pupillary response across nine log-incremental steps of light intensity (left to right) in Bangladesh (a), Kenya (b), Zambia (c), and
Peru (d). Pupillary response is defined as the percent change in pupil diameter from pre- to post-stimulus
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Conclusions
Field testing of the PFDA confirmed its ease of use for
measuring dark adaptation, even under challenging field
conditions. Testing in four populations clearly replicated
the well-recognized linear relationship between pupillary
responsiveness over log-incremental increases in light
intensity. We also noted faster response times at the
lower light intensity stimuli, indicative of the slight
pupillary fatigue experienced between the beginning of
the test, after 10 min of dark adaptation, and the nine
consecutive, log-incremental pupillary stimuli. The indi-
ces of pupillary response and pupil dynamics generated
here from PFDA measurements are not exhaustive.
However, we do recommend that future PFDA studies
report pupillary threshold to ensure comparability with
previous research [7], and in the case of vitamin A
deficiency-related research, consider a similar focus on
the high light intensity stimuli.
The PFDA was initially designed for use in public
health nutrition research and practice. Based on the pre-
vious findings showing a direct relationship between
pupillary responsiveness and serum retinol concentra-
tion [8, 14, 15] and modified dose response [8], the
PFDA is currently undergoing validation as a tool to
screen populations for vitamin A deficiency. It also being
employed in efficacy trials of provitamin A carotenoid
biofortified foods [21], where dark adaptation is a pri-
mary functional outcome. There are potential applica-
tions for the PFDA in research on non-communicable
diseases and clinical practice as well. For example, it
might serve as a rapid and non-invasive status test for
patients with complex gastrointestinal and hepatobiliary
conditions linked to poor vitamin A absorption [22].
Dark adaptometry can also be employed in the diagnosis
of age-related macular degeneration, photoreceptor dys-
trophies, and glaucoma [23–25]. Finally, there is a well-
established, causal relationship between poor scotopic
vision and hypoxemia [3], which suggests a potential ap-
plication of this device in the search for early predictors
of cardiopulmonary disease.
Additional files
Additional file 1: Example PFDA video from a child with normal
dark adaptation.
Additional file 2: Example PFDA video file from a child with
abnormal dark adaptation.
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